Nicole LaBrosse - Feb 15, 2022 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, Chief Financial Officer
Signature
/s/ James R. Oehler as attorney-in-fact for Nicole LaBrosse
Stock symbol
HALO
Transactions as of
Feb 15, 2022
Transactions value $
-$14,908
Form type
4
Date filed
2/17/2022, 05:03 PM
Previous filing
Feb 14, 2022
Next filing
Nov 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Options Exercise $0 +1.26K +15.26% $0.00 9.48K Feb 15, 2022 Direct
transaction HALO Common Stock Tax liability -$14.9K -433 -4.57% $34.43 9.05K Feb 15, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HALO Restricted Stock Units Options Exercise $0 -1.26K -25.01% $0.00 3.76K Feb 15, 2022 Common Stock 1.26K $0.00 Direct F2
transaction HALO Option to Purchase Common Stock Award $0 +62.3K $0.00 62.3K Feb 16, 2022 Common Stock 62.3K $34.36 Direct F3
transaction HALO Restricted Stock Units Award $0 +20.4K $0.00 20.4K Feb 16, 2022 Common Stock 20.4K $0.00 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported disposition of 433 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.
F2 This transaction represents the vesting and settlement of restricted stock units in shares of common stock of the issuer.
F3 This option vests one-fourth on such date and then 1/48th monthly thereafter.
F4 This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary thereafter.